In the realm of pharmaceutical development, peptides have emerged as a potent class of therapeutic agents. Theirs efficacy stems from their ability to precisely target cellular processes. However, ensuring the quality and safety of peptide therapeutics is paramount. This necessitates adherence to

Eli Lilly, now the world's most valuable healthcare company by market capitalization, has seen its shares soar 62.5% this year due to high demand for their diabetes drug Mounjaro. The company plans to invest $5.3 billion to expand production capacity for its widespread obesity and diabetes drugs